Literature DB >> 25804828

Paired TCRαβ analysis of virus-specific CD8(+) T cells exposes diversity in a previously defined 'narrow' repertoire.

Tania Cukalac1, Wan-Ting Kan1, Pradyot Dash2, Jing Guan1, Kylie M Quinn1, Stephanie Gras3,4, Paul G Thomas2, Nicole L La Gruta1.   

Abstract

T-cell receptor (TCR) usage has an important role in determining the outcome of CD8(+) cytotoxic T-lymphocyte responses to viruses and other pathogens. However, the characterization of TCR usage from which such conclusions are drawn is based on exclusive analysis of either the TCRα chain or, more commonly, the TCRβ chain. Here, we have used a multiplexed reverse transcription-PCR protocol to analyse the CDR3 regions of both TCRα and β chains from single naive or immune epitope-specific cells to provide a comprehensive picture of epitope-specific TCR usage and selection into the immune response. Analysis of TCR repertoires specific for three influenza-derived epitopes (D(b)NP(366), D(b)PA(224) and D(b)PB1-F2(62)) showed preferential usage of particular TCRαβ proteins in the immune repertoire relative to the naive repertoire, in some cases, resulting in a complete shift in TRBV preference or CDR3 length, and restricted repertoire diversity. The NP(366)-specific TCRαβ repertoire, previously defined as clonally restricted based on TCRβ analysis, was similarly diverse as the PA(224)- and PB1-F2(62)-specific repertoires. Intriguingly, preferred TCR characteristics (variable gene usage, CDR3 length and junctional gene usage) appeared to be able to confer specificity either independently or in concert with one another, depending on the epitope specificity. These data have implications for established correlations between the nature of the TCR repertoire and response outcomes after infection, and suggest that analysis of a subset of cells or a single TCR chain does not accurately depict the nature of the antigen-specific TCRαβ repertoire.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25804828      PMCID: PMC4618100          DOI: 10.1038/icb.2015.44

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  70 in total

1.  Antigen-driven selection of TCR In vivo: related TCR alpha-chains pair with diverse TCR beta-chains.

Authors:  J A Mikszta; L J McHeyzer-Williams; M G McHeyzer-Williams
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

2.  Measuring T cell receptor and T cell gene expression diversity in antigen-responsive human CD4+ T cells.

Authors:  Anne Eugster; Annett Lindner; Anne-Kristin Heninger; Carmen Wilhelm; Sevina Dietz; Mara Catani; Anette-G Ziegler; Ezio Bonifacio
Journal:  J Immunol Methods       Date:  2013-11-13       Impact factor: 2.303

3.  Acute emergence and reversion of influenza A virus quasispecies within CD8+ T cell antigenic peptides.

Authors:  Sophie A Valkenburg; Sergio Quiñones-Parra; Stephanie Gras; Naomi Komadina; Jodie McVernon; Zhongfang Wang; Hanim Halim; Pina Iannello; Catherine Cole; Karen Laurie; Anne Kelso; Jamie Rossjohn; Peter C Doherty; Stephen J Turner; Katherine Kedzierska
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

4.  A new cloning and expression system yields and validates TCRs from blood lymphocytes of patients with cancer within 10 days.

Authors:  Eiji Kobayashi; Eishiro Mizukoshi; Hiroyuki Kishi; Tatsuhiko Ozawa; Hiroshi Hamana; Terumi Nagai; Hidetoshi Nakagawa; Aishun Jin; Shuichi Kaneko; Atsushi Muraguchi
Journal:  Nat Med       Date:  2013-10-13       Impact factor: 53.440

Review 5.  T cell antigen receptor recognition of antigen-presenting molecules.

Authors:  Jamie Rossjohn; Stephanie Gras; John J Miles; Stephen J Turner; Dale I Godfrey; James McCluskey
Journal:  Annu Rev Immunol       Date:  2014-12-10       Impact factor: 28.527

6.  Reproducible selection of high avidity CD8+ T-cell clones following secondary acute virus infection.

Authors:  Tania Cukalac; Jesseka Chadderton; Andreas Handel; Peter C Doherty; Stephen J Turner; Paul G Thomas; Nicole L La Gruta
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

7.  Fixed expression of single influenza virus-specific TCR chains demonstrates the capacity for TCR α- and β-chain diversity in the face of peptide-MHC class I specificity.

Authors:  E Bridie Clemens; Peter C Doherty; Nicole L La Gruta; Stephen J Turner
Journal:  J Immunol       Date:  2014-12-22       Impact factor: 5.422

8.  Contemporary analysis of MHC-related immunodominance hierarchies in the CD8+ T cell response to influenza A viruses.

Authors:  G T Belz; P G Stevenson; P C Doherty
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

9.  T-cell receptor recognition of HLA-DQ2-gliadin complexes associated with celiac disease.

Authors:  Jan Petersen; Veronica Montserrat; Jorge R Mujico; Khai Lee Loh; Dennis X Beringer; Menno van Lummel; Allan Thompson; M Luisa Mearin; Joachim Schweizer; Yvonne Kooy-Winkelaar; Jeroen van Bergen; Jan W Drijfhout; Wan-Ting Kan; Nicole L La Gruta; Robert P Anderson; Hugh H Reid; Frits Koning; Jamie Rossjohn
Journal:  Nat Struct Mol Biol       Date:  2014-04-28       Impact factor: 15.369

Review 10.  Interrogating the relationship between naïve and immune antiviral T cell repertoires.

Authors:  Nicole L La Gruta; Paul G Thomas
Journal:  Curr Opin Virol       Date:  2013-07-10       Impact factor: 7.090

View more
  16 in total

Review 1.  Sizing up the key determinants of the CD8(+) T cell response.

Authors:  David C Tscharke; Nathan P Croft; Peter C Doherty; Nicole L La Gruta
Journal:  Nat Rev Immunol       Date:  2015-10-09       Impact factor: 53.106

2.  Heightened self-reactivity associated with selective survival, but not expansion, of naïve virus-specific CD8+ T cells in aged mice.

Authors:  Kylie M Quinn; Sophie G Zaloumis; Tania Cukalac; Wan-Ting Kan; Xavier Y X Sng; Michiko Mirams; Katherine A Watson; James M McCaw; Peter C Doherty; Paul G Thomas; Andreas Handel; Nicole L La Gruta
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-19       Impact factor: 11.205

3.  Structural Basis for Clonal Diversity of the Public T Cell Response to a Dominant Human Cytomegalovirus Epitope.

Authors:  Xinbo Yang; Mingming Gao; Guobing Chen; Brian G Pierce; Jinghua Lu; Nan-Ping Weng; Roy A Mariuzza
Journal:  J Biol Chem       Date:  2015-10-01       Impact factor: 5.157

4.  Selected before selection: A case for inherent antigen bias in the T cell receptor repertoire.

Authors:  Paul G Thomas; Jeremy Chase Crawford
Journal:  Curr Opin Syst Biol       Date:  2019-11-06

5.  Overlapping Peptides Elicit Distinct CD8+ T Cell Responses following Influenza A Virus Infection.

Authors:  Lisa M Assmus; Jing Guan; Ting Wu; Carine Farenc; Xavier Y X Sng; Pirooz Zareie; Angela Nguyen; Andrea T Nguyen; David C Tscharke; Paul G Thomas; Jamie Rossjohn; Stephanie Gras; Nathan P Croft; Anthony W Purcell; Nicole L La Gruta
Journal:  J Immunol       Date:  2020-08-31       Impact factor: 5.422

6.  Selection influences naive CD8+ TCR-β repertoire sharing.

Authors:  Hao H Yiu; Louis N Schoettle; Marlene Garcia-Neuer; Joseph N Blattman; Philip L F Johnson
Journal:  Immunology       Date:  2021-01-11       Impact factor: 7.397

Review 7.  Mathematics in modern immunology.

Authors:  Mario Castro; Grant Lythe; Carmen Molina-París; Ruy M Ribeiro
Journal:  Interface Focus       Date:  2016-04-06       Impact factor: 3.906

8.  Single-cell TCRseq: paired recovery of entire T-cell alpha and beta chain transcripts in T-cell receptors from single-cell RNAseq.

Authors:  David Redmond; Asaf Poran; Olivier Elemento
Journal:  Genome Med       Date:  2016-07-27       Impact factor: 11.117

9.  Identifying T Cell Receptors from High-Throughput Sequencing: Dealing with Promiscuity in TCRα and TCRβ Pairing.

Authors:  Edward S Lee; Paul G Thomas; Jeff E Mold; Andrew J Yates
Journal:  PLoS Comput Biol       Date:  2017-01-19       Impact factor: 4.475

10.  T cell receptor sequencing in autoimmunity.

Authors:  Angela M Mitchell; Aaron W Michels
Journal:  J Life Sci (Westlake Village)       Date:  2020-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.